The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

OBJECTIVE: To explore the efficacy and safety of EGFR-TKI combined with thymosin therapy in advanced non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations. METHODS: Patients confirmed as advanced NSCLC with active EGFR mutations were recruited from August 2008 to July 2018 retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yongdong, Zhu, Guangkuo, Lang, Song, Hao, Ping, Li, Guanghui, Chen, Fanglin, Zhuo, Wenlei, Duan, Yuzhong, Zhang, Anmei, Chen, Zhengtang, Sun, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195272/
https://www.ncbi.nlm.nih.gov/pubmed/34123814
http://dx.doi.org/10.3389/fonc.2021.659065

Ejemplares similares

Ejemplares similares